91Ó°ÊÓ

Short-term securities are financial instruments that are intended to be held for a short period, typically less than one year. Companies like Oncogene Science, Inc. often invest in these securities as a way to manage their cash flows and maximize returns on excess cash. Typical types of short-term securities include Treasury bills, commercial paper, and certificates of deposit.

In the context of financial statement analysis, these short-term investments are important as they provide liquidity and demonstrate a company's ability to quickly convert assets into cash. This flexibility is crucial for meeting operational needs or taking advantage of investment opportunities.

When examining a company's financial statements, it’s helpful to look at the notes for more detailed disclosures about the types of short-term securities held and any associated risks or returns.

SFAS No. 115 stands for the Statement of Financial Accounting Standards No. 115, which provides guidelines on how to account for certain investments in debt and equity securities. According to SFAS No. 115, companies must classify their investments based on their intended purpose and how long they expect to hold them.

• Trading Securities: Bought with the intention of selling in the near term to profit from short-term price movements.
• Available-for-Sale Securities: Not classified under trading or held-to-maturity. These can be sold as needed, but not necessarily in the immediate term.
• Held-to-Maturity Securities: Debt securities that a company plans to hold until they mature.

Companies must report these classifications in their financial statements, which influences how gains and losses are recorded.

Investment classification pertains to how a company categorizes its investments based on their intended use and holding period. This classification dictates how these investments are reported on financial statements, affecting both income and financial position.

Oncogene Science, Inc. would classify its short-term investments into one of three categories: trading, held-for-sale, or held-to-maturity. The classification impacts several factors:

• Trading Securities: Gains or losses from changes in fair value are recognized immediately in the income statement.
• Available-for-Sale Securities: Changes in fair value are recorded in other comprehensive income until sold.
• Held-to-Maturity Securities: Held at amortized cost without recognizing unrealized gains or losses on the income statement.

Understanding these classifications helps in assessing a company's financial strategies and risk management.

The income statement is a financial report that shows a company's revenue, expenses, and profits over a specific period. Financial investments, like short-term securities, can impact various parts of the income statement.

For trading securities, any unrealized gains or losses due to changes in market value appear in the income statement. These changes affect the company's net income directly. Oncogene Science, Inc.’s income statement will reflect investment income from any interest, dividends, or realized capital gains from the sale of securities.

This inclusion can result in fluctuations in profitability, demonstrating how investment strategies can impact overall financial performance. Such insights are vital for stakeholders looking to evaluate the company’s short-term performance and growth potential.

The balance sheet provides a snapshot of a company's financial position at a specific point in time by detailing assets, liabilities, and shareholders' equity. Short-term securities are typically reflected under current assets.

Depending on their classification, securities are recorded at fair value or amortized cost, which affects the asset side of the balance sheet. For instance:

• Trading and Available-for-Sale Securities: Reported at fair value, showing the current market value.
• Held-to-Maturity Securities: Listed at amortized cost, not reflecting current market fluctuations.

By reviewing these entries, one can understand how liquid a company's assets are and how prepared they are to fulfill short-term obligations.

The statement of shareholders' equity outlines changes in equity from net earnings, dividends, issuance, and repurchase of shares. It also reflects movements in other comprehensive income, often linked to available-for-sale securities.

For Oncogene Science, Inc., investing in available-for-sale securities means unrealized gains and losses are recorded here until the securities are sold. This allows investors to see potential future financial impacts without affecting net income immediately.

In essence, this statement helps stakeholders understand how investment strategies might affect equity value, providing insight into long-term financial health beyond merely net earnings.

The statement of cash flows outlines the cash impact of a company's operations, investments, and financing activities over a period. Investments in short-term securities appear in the investing section of this statement.

Acquisitions of short-term securities are recognized as cash outflows, while proceeds from sales or maturities are cash inflows. Oncogene Science, Inc. reflects these transactions, illustrating their effect on overall liquidity.

This statement is particularly useful for evaluating a company’s ability to generate cash and manage liquidity, factors crucial for ensuring the company can meet obligations and sustain growth. Understanding the cash flow impact of investment activities is key to assessing financial flexibility.